ロード中...
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia
Treatment of acute myeloid leukaemia (AML) is challenging and emerging treatment options include protein phosphatase 2A (PP2A) activators. Fingolimod is a known PP2A activator that inhibits multiple signalling pathways and has been used extensively in patients with multiple sclerosis and other indic...
保存先:
| 出版年: | Anticancer Drugs |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4881728/ https://ncbi.nlm.nih.gov/pubmed/26967515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|